These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15689456)

  • 1. Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or "deletion with positional effect" syndrome?
    Redon R; Rio M; Gregory SG; Cooper RA; Fiegler H; Sanlaville D; Banerjee R; Scott C; Carr P; Langford C; Cormier-Daire V; Munnich A; Carter NP; Colleaux L
    J Med Genet; 2005 Feb; 42(2):166-71. PubMed ID: 15689456
    [No Abstract]   [Full Text] [Related]  

  • 2. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients.
    Van Buggenhout G; Van Ravenswaaij-Arts C; Mc Maas N; Thoelen R; Vogels A; Smeets D; Salden I; Matthijs G; Fryns JP; Vermeesch JR
    Eur J Med Genet; 2005; 48(3):276-89. PubMed ID: 16179223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions.
    Ballif BC; Yu W; Shaw CA; Kashork CD; Shaffer LG
    Hum Mol Genet; 2003 Sep; 12(17):2153-65. PubMed ID: 12915474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome.
    Kurosawa K; Kawame H; Okamoto N; Ochiai Y; Akatsuka A; Kobayashi M; Shimohira M; Mizuno S; Wada K; Fukushima Y; Kawawaki H; Yamamoto T; Masuno M; Imaizumi K; Kuroki Y
    Brain Dev; 2005 Aug; 27(5):378-82. PubMed ID: 16023556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions.
    Yu W; Ballif BC; Kashork CD; Heilstedt HA; Howard LA; Cai WW; White LD; Liu W; Beaudet AL; Bejjani BA; Shaw CA; Shaffer LG
    Hum Mol Genet; 2003 Sep; 12(17):2145-52. PubMed ID: 12915473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma.
    Isidor B; Le Cunff M; Boceno M; Boisseau P; Thomas C; Rival JM; David A; Le Caignec C
    Eur J Med Genet; 2008; 51(6):679-84. PubMed ID: 18672103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
    Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
    Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal interstitial 1p36 deletion syndrome: the most proximal 3.5-Mb microdeletion identified on a dysmorphic and mentally retarded patient with inv(3)(p14.1q26.2).
    Shimojima K; Páez MT; Kurosawa K; Yamamoto T
    Brain Dev; 2009 Sep; 31(8):629-33. PubMed ID: 18835671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proximal 1p36 deletions using array-CGH: a possible new syndrome.
    Kang SH; Scheffer A; Ou Z; Li J; Scaglia F; Belmont J; Lalani SR; Roeder E; Enciso V; Braddock S; Buchholz J; Vacha S; Chinault AC; Cheung SW; Bacino CA
    Clin Genet; 2007 Oct; 72(4):329-38. PubMed ID: 17850629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosomy 1p36.
    Slavotinek A; Shaffer LG; Shapira SK
    J Med Genet; 1999 Sep; 36(9):657-63. PubMed ID: 10507720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
    Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
    Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the "extended" phenotype.
    Giannikou K; Fryssira H; Oikonomakis V; Syrmou A; Kosma K; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
    Gene; 2012 Sep; 506(2):360-8. PubMed ID: 22766398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q.
    Hermsen MA; Tijssen M; Acero IH; Meijer GA; Ylstra B; Toral JF
    Eur J Med Genet; 2005; 48(3):310-8. PubMed ID: 16179226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Del 1p36 syndrome: a newly emerging clinical entity.
    Battaglia A
    Brain Dev; 2005 Aug; 27(5):358-61. PubMed ID: 16023552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrowing the deleted region associated with the 15q21 syndrome.
    Pramparo T; Mattina T; Gimelli S; Liehr T; Zuffardi O
    Eur J Med Genet; 2005; 48(3):346-52. PubMed ID: 16179230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic, FISH and array-CGH characterization of a complex chromosomal rearrangement carried by a mentally and language impaired patient.
    Ballarati L; Recalcati MP; Bedeschi MF; Lalatta F; Valtorta C; Bellini M; Finelli P; Larizza L; Giardino D
    Eur J Med Genet; 2009; 52(4):218-23. PubMed ID: 19236961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virilization of the external genitalia and severe mental retardation in a girl with an unbalanced translocation 1;18.
    de Pater JM; Poot M; Beemer FA; Bijlsma JB; Hack WW; Van Dam WM; Eleveld MJ; Loneus WH; Engelen JJ
    Eur J Med Genet; 2006; 49(1):19-27. PubMed ID: 16473306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndrome.
    Wakui K; Gregato G; Ballif BC; Glotzbach CD; Bailey KA; Kuo PL; Sue WC; Sheffield LJ; Irons M; Gomez EG; Hecht JT; Potocki L; Shaffer LG
    Eur J Hum Genet; 2005 May; 13(5):528-40. PubMed ID: 15852040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prader-Willi-like phenotype: investigation of 1p36 deletion in 41 patients with delayed psychomotor development, hypotonia, obesity and/or hyperphagia, learning disabilities and behavioral problems.
    D'Angelo CS; Da Paz JA; Kim CA; Bertola DR; Castro CI; Varela MC; Koiffmann CP
    Eur J Med Genet; 2006; 49(6):451-60. PubMed ID: 16564757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.